Beroni Group Inc (OTCQX:BNIGF ) (NSX:BTG) CEO Jacky Zhang sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Australian-based company currently has four core businesses: research and development of new drugs and clinical trail, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.
Beroni Group looking to up-list to the Nasdaq
You Might Also Like
Beroni China (product: SARS-CoV-2 IgG/IgM Antibody Detection Kit) is included in the List of Medical Devices and Supplies Companies with Certification/Authorization from Other Countries
Beroni Group Collaborates with Tianjin University to Develop Novel Solution for Coronavirus (COVID-19)
